Andrew H. Ko

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Discovering dominant tumor immune archetypes in a pan-cancer census”.

Discovering dominant tumor immune archetypes in a pan-cancer census

Cell(2021)10.1016/j.cell.2021.12.004

N/A

4.2DataRank · unranked

176 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +75 more

Hyperpolarized 13C Metabolic MRI of Patients with Pancreatic Ductal Adenocarcinoma

Journal of Magnetic Resonance Imaging(2023)10.1002/jmri.29162

N/A

0.567DataRank · unranked

20 citations

Hsin‐Yu Chen, Tanner Nickles, Philip Lee, Robert Bok, Michael A. Ohliger +5 more

Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer

The Oncologist(2020)10.1634/theoncologist.2019-0282

N/A

0DataRank · unranked

27 citations

Margaret Zhou, Alan Paciorek, Chloé E. Atreya, Andrew H. Ko, Alan P. Venook +3 more

Variability in multimodality treatment influences survival in non- metastatic gastric cancer patients

Journal of Gastrointestinal Oncology(2020)10.21037/jgo-20-212

N/A

0DataRank · unranked

1 citations

Farshid Dayyani, Ariceli A. Alfaro, Jasmine Huynh, Jingran Ji, Andrew H. Ko +3 more

Pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Final outcomes of a phase 2 trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.444

N/A

0DataRank · unranked

9 citations

Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, Faaiz Ibrahim, M. Pollak +8 more

Optimizing pancreatic cancer management with next generation imaging and liquid biopsy (CHANGE-PDAC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps640

N/A

0DataRank · unranked

0 citations

Eric A. Collisson, Zhen J. Wang, Sorbarikor Piawah, Taylor Sanchez, Margaret A. Tempero +2 more

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3978

N/A

0DataRank · unranked

152 citations

Todd S. Crocenzi, Jennifer N. Durham, Elizabeth A. Sugar, Annie A. Wu, Beth Onners +16 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer

Molecular Therapy(2020)10.1016/j.ymthe.2020.07.017

N/A

0DataRank · unranked

56 citations

Alexander C. Jordan, Evan Tooker, Simon F. Lacey, Renee B. Chang, Yan Li +11 more